Fan Jie, president of Huawei's pharmaceutical division, clarifies that 'Huawei does not make drugs,' aiming instead to become the technological foundation for the AI drug discovery industry.

Addressing concerns about whether Huawei will directly enter drug R&D, Fan Jue stated: 'Huawei does not make drugs, nor do we develop pipelines.' Instead, Huawei aims to leverage its strengths in computing, communications, and artificial intelligence to provide computing power, storage, networking, toolchains, and data governance capabilities for pharmaceutical companies, research institutions, and AI drug discovery firms, becoming the technological foundation and ecosystem supporter of the AI drug discovery industry.